Check out our Kolling Institute Year in Review 2022 celebrating our research success. It highlights our world-leading translational research and our impact across our priority research areas. Click on the link here.
Read more

Researchers at the Kolling Institute have made important progress towards the development of new treatments for chronic pain by identifying a small group of cells which can control pain responses. The breakthrough comes as approximately 20 per cent of the world’s population suffers from chronic pain, including around 3.4 million Australians. Dr Neda Assareh, a neuroscientist research fellow from th.....
Read more

In a sign of the growing neuroscience expertise at the Kolling Institute, internationally recognised Meniere’s disease expert Professor Jose Antonio Lopez Escamez has relocated from Spain to the institute. Professor Lopez Escamez has launched an exciting new international research program into the disease, extending his body of work in Europe. Meniere’s disease is a rare disease of the inner ear th.....
Read more

We are pleased to announce the successful recipients of our annual Kolling Institute awards program. Launched in 2021, the program has been expanded to acknowledge a greater number of researchers and their individual contribution to the Kolling. The awards aim to recognise the many outstanding achievements across education, clinical practice and service, publications, research, as well as overall a.....
Read more

A new study by researchers at the Kolling Institute, in collaboration with the Microbiome Research Centre, has shown that multiple medication use impacts gut microbiome, and may influence the ageing process. Gizem Gemikonakli, a PhD student at the University of Sydney, said their findings followed a longitudinal, in vivo study. “Interestingly, mice that were given a regimen of five therapeutic medi.....
Read more

A simple yet smart approach may hold the key to greatly improved health for those with life-changing spinal cord injuries. Researchers from the Kolling Institute’s John Walsh Centre for Rehabilitation Research are launching a project to assess whether a specific breathing technique can improve many of the challenges faced by people with a spinal cord injury, like chronic pain, life threatening unst.....
Read more

Researchers at the Kolling Institute have taken an important step towards the development of safer, non-addictive pain medications by increasing our understanding of spinal cord pain signalling. This valuable progress has been recognised internationally with publication in the Journal of Physiology, a leading scientific journal. The findings follow the latest figures indicating more than 20 per cen.....
Read more

An impressive group of emerging leaders addressed the Kolling’s Neuroscience and Pain Showcase, sharing details of their diverse and exciting research projects. With a broad range of expertise in this field, the showcase involved representatives from the pain management and rehabilitations teams, as well as the ageing, mental health, neurogenetics and neuromuscular imaging groups. The early and mid.....
Read more

New research by a team from the Kolling Institute has found the best treatment for chronic low back pain doesn’t just focus on the physical, but combines physiotherapy treatments with those focusing on the mind. The study, involving Emma Ho, Professor Manuela Ferreira and Lingxiao Chen, analysed evidence from almost 100 trials worldwide involving over 13,000 patients. It found a combination of phys.....
Read more

Clinicians, researchers and patients have welcomed a landmark law which will pave the way for remarkable new IVF technology to prevent mitochondrial disease. Known as “Maeve’s law” after a young Victorian girl with a rare genetic disorder, the legislation was passed by Federal Parliament allowing the specialised IVF procedure to be carried out in Australia. It will involve replacing faulty mitochon.....
Read more